Multiple Myeloma Market Projection by Technology, Top Key Players, Growth, Revenue, CAGR, Regional Analysis Industry Forecast - 2028

0
0

A new market study, titled “Multiple Myeloma Market Forecast 2021-2028” has been featured on Fortune Business Insights™.

 

***Get Latest Updated Market Research Report with Free Sample Report

Market Overview:

The global multiple myeloma market size is projected to reach USD 31 billion by the end of 2026. The high prevalence of the disease will emerge in favor of the companies operating in the market. According to a report published by Fortune Business Insights, titled “Multiple Myeloma Market Size, Share & Industry Analysis, By Drug Class (Immunomodulators, Proteasome Inhibitor, Anti-CD38 Monoclonal Antibody, Alkylating Agents, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies), and Regional Forecast, 2019-2026,” the market was worth USD 19.48 billion in 2018 and will exhibit a CAGR of 6.0% during the forecast period, 2019-2026.

Request for Free Sample Report PDF @ https://www.fortunebusinessinsights.com/enquiry/sample/multiple-myeloma-market-102693

Multiple myeloma is a rare form of cancer that has a direct impact on the blood in the human body. Due to the effects of blood disorders, there has been a huge emphasis on the development of drugs associated with the treatment of the disease. The increasing investment in the R&D of products by large scale companies across the world will bode well for the market in recent years. Advances in ongoing clinical trials associated with the treatment of the disease, will open up a huge potential for the companies operating in the market. The presence of several large scale companies will bode well for the market in the foreseeable future.

Increasing Investment in Product R&D Will Aid Growth

The report encompasses several factors that have contributed to the growth of the market in recent years. Among all factors, high investment in research and development of newer products has made a huge impact on the growth of the overall market. In April 2019, the ‘Multiple Myeloma Research Foundation’ announced the launch of a new investment fund for the treatment options in multiple myeloma. The MMRF introduced ‘Myeloma Investment Fund’ foe the development of clinical trials of ongoing drugs associated with the treatment of the disease. This investment will have a massive impact on the growth of the overall market in the coming years.

North America Currently Dominates the Market; Increasing Investment in Product R&D by Major Companies to Aid Growth

The report analyzes the ongoing multiple myeloma market trends across North America, Latin America, Asia Pacific, the Middle East and Africa, and Europe. Among these regions, the market in North America currently dominates the market. The high investment put in by government and leading organizations will bode well for the market in North America. As of 2018, the market in North America was worth USD 11.40 billion and this value is projected to increase further in the coming years. The market in Europe will emerge as the second largest market in the coming years, driven by the presence of several large scale companies in several countries across this region.

Ask for Customization @ https://www.fortunebusinessinsights.com/enquiry/customization/multiple-myeloma-market-102693

A few of the leading companies that are operating in the global multiple myeloma market include:

  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Bristol Myers Squibb Company
  • Amgen Inc.
  • ONO PHARMACEUTICAL CO., LTD.
  • Janssen Pharmaceuticals, Inc.
  • Genentech, Inc. (F. Hoffmann-La Roche Ltd)
  • CELGENE CORPORATION (Bristol Myers Squibb Company)
  • AbbVie Inc.
  • Sanofi
  • Karyopharm
  • Others

Industry Developments:

December 2019: The first clinical data released for BCMAxCD3 bispecific antibody, showed positive preliminary results for the treatment of multiple myeloma.

 

Table Of Content:

  1. Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  4. Key Insights
    • Prevalence of Multiple Myeloma – by Key Countries – 2018
    • Pipeline Analysis
    • Key Industry Developments
    • Regulatory Scenario, by Key Regions
    • Analysis Of Economic Burden of Multiple Myeloma Treatment
    • New Product Launches
    • Overview of Emerging Treatments for Multiple Myeloma
  5. Global Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  1. North America Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis – By Country
      • S.
      • Canada
  1. Europe Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis – By Country/ sub-region
      • K.
      • Germany
      • France
      • Spain
      • Italy
      • Scandinavia
      • Rest of Europe
  1. Asia pacific Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis – By Country/ sub-region
      • Japan
      • China
      • India
      • Australia
      • Southeast Asia
      • Rest of Asia Pacific
  1. Latin America Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis – By Country/ sub-region
      • Brazil
      • Mexico
      • Rest of Latin America
  1. Middle East & Africa Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis – By Country/ sub-region
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
  1. Competitive Analysis
    • Key Industry Developments
    • Global Market Share Analysis (2017)
    • Competition Dashboard
    • Comparative Analysis – Major Players
    • Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      • Takeda Pharmaceutical Company Limited
      • Novartis AG
      • Teva Pharmaceutical Industries Ltd.
      • Bristol Myers Squibb Company
      • Amgen Inc.
      • ONO PHARMACEUTICAL CO., LTD.
      • Janssen Pharmaceuticals, Inc.
      • Genentech, Inc. (F. Hoffmann-La Roche Ltd)
      • CELGENE CORPORATION (Bristol Myers Squibb Company)
      • AbbVie Inc.
      • Sanofi
      • Other Prominent Players
  1. Strategic Recommendation

Continued. . .

Related Article @ https://marketresearchreportsfbi.wordpress.com/2021/11/08/autotransfusion-devices-market-by-technology-share-size-segmentation-revenue-analysis-forecast-2028/

NOTE: Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

LinkedIn: https://www.linkedin.com/company/fortune-business-insights

Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd

Twitter: https://twitter.com/FBInsightPvtLtd

Showing 0 results
Your Answer

Please first to submit.

Get involved

Register

As a member of this site you will be able to receive aggregates news relating only to those categories that are most relevant to you, submit job listings for FREE, post questions in the Q&A, and more.

Register Now

Feature your company

The Feature Your Company listing is your custom-made (by us) profile page that allows you to add any of the following content: text, videos, links, images. The page will also be listed on the Featured Company landing page. Over 560 unique aggregates users visit the site per day! Complete the enquiry form now to contact us.

Contact us

Jobs

Are you looking for an aggregate related job? Click here to see our jobs listing supplied by industry experts United Employment.

See Jobs

Advertise

Reach thousands of budget holders and decision makers by promoting your company on the longest established aggregate website in the US & Canada. Or advertise in our emails which are sent to opted-in subscribers according to their chosen categories. All advertising will display correctly on tablets and mobiles as this site is responsive.